Bestrophin 4 Antikörper (N-Term)
Kurzübersicht für Bestrophin 4 Antikörper (N-Term) (ABIN630067)
Target
Alle Bestrophin 4 (BEST4) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- VMD2 L2 antibody was raised against the N terminal Of Vmd2 2
-
Aufreinigung
- Purified
-
Immunogen
- VMD2 L2 antibody was raised using the N terminal Of Vmd2 2 corresponding to a region with amino acids MTVSYTLKVAEARFGGFSGLLLRWRGSIYKLLYKEFLLFGALYAVLSITY
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
VMD2L2 Blocking Peptide, (ABIN5616970), is also available for use as a blocking control in assays to test for specificity of this VMD2L2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of VMD0 2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Bestrophin 4 (BEST4)
-
Andere Bezeichnung
- VMD2L2
-
Hintergrund
- VMD2L2 is 1 of 3 VMD2-like genes which encode transmembrane spanning proteins that share a homology region with a high content of aromatic residues including an invariant arginine (R), phenylalanine (F), and proline (P) motif.
-
Molekulargewicht
- 52 kDa (MW of target protein)
Target
-